skip to content

Cambridge Immunology Network

 

Molecular Immunity Unit at the MRC Laboratory of Molecular Biology

Infectious diseases remain the major cause of mortality and morbidity throughout the world and their occurrence represents a failure of the immune system. In spite of this, however, our very existence demonstrates that our immune system has the capability to successfully cope with these diseases.

The goal of the Department of Medicine Molecular Immunity Unit (MIU) is to better understand the fundamental mechanisms that govern microbial pathogenesis, how the immune system can control these infections and what happens when the immune system fails and turns against our own bodies. This requires a wide spectrum of research using complementary approaches that span all scales of biology; from atomic-level structural analysis to studies of human patient cohorts.

This spectrum covers the interface between molecular biology and clinical medicine. Embedded within the MRC Laboratory of Molecular Biology, the MIU views itself as a bridge between these two areas. The Unit's size and distribution of interests are intended to be broad enough to bring about important and medically relevant research but small enough to be a cohesive research facility.


Principal Investigators

Dr Menna   Clatworthy
University Lecturer in Transplantation Medicine
Professor Andres  Floto
Professor of Respiratory Biology
Wellcome Trust Senior Investigator
Dr John  James
Sir Henry Dale Fellow (Wellcome Trust)
01223 267280
Professor Yorgo  Modis
Wellcome Trust Senior Research Fellow
+44/0 1223 267282

Clinicians

Dr Menna   Clatworthy
University Lecturer in Transplantation Medicine
Professor Andres  Floto
Professor of Respiratory Biology
Wellcome Trust Senior Investigator

The new Jeffrey Cheah Biomedical Centre - CITIID

See the home of CITIID being built in this fantastic time-lapse video. From basement to water tight in 17 months. The Jeffrey Cheah Bimedical Centre is now complete and home to the Cambridge Immunology Network Coordinator.

Fibroblast

‘Fibroblast’ has been developed from a conversation between Harold Offeh and Dr Alice Denton, a scientist based at the Babraham Institute and a member of the Cambridge Immunology Network. Offeh was particularly interested in the character and roles played by particular cells in the immune system, as well as the immune system’s role as a primary source of protection and care. The film takes as a starting point microscopic images of broblast cells, an area of research for Dr Denton.